In contrast, markers such as pro-gastrin-releasing peptide (ProGRP) and carbohydrate antigen 19-9 (CA19-9) remain of limited clinical relevance in MTC but may have contextual significance in aggressive or dedifferentiated disease. The gene discussed is GRP; the disease is medullary thyroid gland carcinoma.